Recombinant multi-species FBXW7/Fbxw7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FBXW7/Fbxw7 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene was previously referred to as FBX30, and belongs to the Fbws class; in addition to an F-box, this protein contains 7 tandem WD40 repeats. This protein binds directly to cyclin E and probably targets cyclin E for ubiquitin-mediated degradation. Mutations in this gene are detected in ovarian and breast cancer cell lines, implicating the gene's potential role in the pathogenesis of human cancers. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2012]
The Alternative Names of target: 1110001A17Rik,AGO,Archipelago homolog (hAgo),CDC4,Cdc4,DEDHIL,F-box and WD-40 domain-containing protein 7,F-box protein FBX30,F-box/WD repeat-containing protein 7,FBW6,FBW7,FBX30,FBXO30,FBXW6,FBXW7,Fbw7,Fbwd6,Fbx30,Fbxo30,Fbxw6,Fbxw7,SEL-10,SEL10,hAgo,hCdc4
Go
to FBXW7/Fbxw7 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP0208-Ag-1/ GM-Tg-hg-IP0208-Ag-2 | Human FBXW7/Fbxw7 protein | Human |
| GM-Tg-rg-IP0208-Ag-1/ GM-Tg-rg-IP0208-Ag-2 | Rat FBXW7/Fbxw7 protein | Rat |
| GM-Tg-mg-IP0208-Ag-1/ GM-Tg-mg-IP0208-Ag-2 | Mouse FBXW7/Fbxw7 protein | Mouse |
| GM-Tg-cynog-IP0208-Ag-1/ GM-Tg-cynog-IP0208-Ag-2 | Cynomolgus/Rhesus macaque FBXW7/Fbxw7 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP0208-Ag-1/ GM-Tg-felg-IP0208-Ag-2 | Feline FBXW7/Fbxw7 protein | Feline |
| GM-Tg-cang-IP0208-Ag-1/ GM-Tg-cang-IP0208-Ag-2 | Canine FBXW7/Fbxw7 protein | Canine |
| GM-Tg-bovg-IP0208-Ag-1/ GM-Tg-bovg-IP0208-Ag-2 | Bovine FBXW7/Fbxw7 protein | Bovine |
| GM-Tg-equg-IP0208-Ag-1/ GM-Tg-equg-IP0208-Ag-2 | Equine FBXW7/Fbxw7 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP0208-Ag-1/ GM-Tg-hg-IP0208-Ag-2;
GM-Tg-rg-IP0208-Ag-1/ GM-Tg-rg-IP0208-Ag-2;
GM-Tg-mg-IP0208-Ag-1/ GM-Tg-mg-IP0208-Ag-2; GM-Tg-cynog-IP0208-Ag-1/ GM-Tg-cynog-IP0208-Ag-2; GM-Tg-felg-IP0208-Ag-1/ GM-Tg-felg-IP0208-Ag-2; GM-Tg-cang-IP0208-Ag-1/ GM-Tg-cang-IP0208-Ag-2; GM-Tg-bovg-IP0208-Ag-1/ GM-Tg-bovg-IP0208-Ag-2; GM-Tg-equg-IP0208-Ag-1/ GM-Tg-equg-IP0208-Ag-2 |
| Products Name | FBXW7/Fbxw7 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | FBXW7/Fbxw7 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine FBXW7/Fbxw7 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.